Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	25.12	88.39	70.65
Graham Fair Price	-15.90	12.89	15.33
PEG	106.32	-0.93	0.45
Price/Book	-11.64	35.61	40.30
Price/Cash Flow	60.33	127.66	79.62
Prices/Earnings	26.95	27.94	22.01
Price/Sales	16.57	29.11	24.97
Price/FCF	60.33	127.66	79.62
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	1.53	0.47	0.46
Operating Margin	-8.95	0.31	0.34
ROA	-26.98	0.07	0.10
ROE	0.46	0.32	-30.40
ROIC	0.19	0.13	-29.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.03	-0.12	72.71
Dividends QOQ	0.02	-0.02	-0.80
EBIT QOQ	0.50	-0.31	-37.84
EPS QOQ	0.49	-0.30	-38.47
FCF QOQ	0.93	-0.45	-51.79
Revenue QOQ	0.34	-0.24	-28.28
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	9.05	11.57	27.77
Days Sales Outstanding (DSO)	37.71	40.81	8.22
Inventory Turnover	9.94	7.78	-21.74
Debt/Capitalization	0.59	0.59	-1.38
Quick Ratio	0.92	0.87	-4.89
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	4.78	4.82	0.80
Cash	4.71	4.36	-7.52
Capex	-0.15	-0.13	15.99
Free Cash Flow	2.42	1.34	-44.45
Revenue	7.71	5.89	-23.59
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.07	1.04	-3.30
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.56	2.44	56.78
Naive Interpretation	Member

06 - Financial Health · Bad

Rating